Passing of Biosecure Act a positive development
Jonathan Hunt MD and CEO, Syngene International analyses that though the change in the Biosecure Act around the timeline of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
regulatory audits
Pricing pressures and regulatory overhang affect margins of Indian pharma companies in FY2023: ICRA
Outlook for the Indian pharma industry remains stable, led by expectations of continued steady revenue growth and comfortable…